Exelixis | EXEL - Piyasa Kapitalizasyonu

Hisse Senedi Fiyatı
41.27
Günlük Değişim
0.01 0.02%
Aylık
-6.23%
Yıllık
11.66%
Q1 Tahmin
40.03




Piyasa Kapitalizasyonu Değişiklik Tarih
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 312M 115M 2026-03
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
Bayer EUR 38.45B 2.09B 2026-03
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
Eisai JPY 1.4T 85.07B 2026-03
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
Exelixis USD 11.75B 959M 2025-12
Genmab DKK 105.72B 85.24B 2026-03
Glaxosmithkline GBP 107.89B 7.96B 2026-03
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
MacroGenics USD 192M 90M 2026-03
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 240.48B 51.73B 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Sanofi EUR 117.34B 2.45B 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Xencor USD 1.09B 256M 2025-12